Pfizer arthritis drug wins new approval in US
The drug is already indicated for adults with rheumatoid arthritis. Celebrex is a medication which is part of a class of drugs known as COX-2 inhibitors. COX-2 inhibitors,
The drug is already indicated for adults with rheumatoid arthritis. Celebrex is a medication which is part of a class of drugs known as COX-2 inhibitors. COX-2 inhibitors,
Treatment with Tracleer in mildly symptomatic pulmonary arterial hypertension (PAH) patients was associated with a highly significant reduction in pulmonary vascular resistance compared to placebo, a primary endpoint
Foradil Certihaler was recalled from the German and Swiss markets in January 2006 because of concerns that accidental mishandling of the device may have resulted in inaccurate dosing
The interim analysis from the head-to-head trial also showed that weekly Abraxane nearly doubled the response rate with less toxicity compared to Abraxane dosed every three weeks. Although
The FDA has recommended the drug’s continued use for community acquired pneumonia, although only as a secondary treatment. The FDA committee concluded that the risks outweigh the benefits
Tibotec said it anticipates receiving the conditional marketing authorization from the European Commission by early next year. The positive opinion is based on the efficacy and safety results
The filing is based on the results of three trials of Tysabri assessing the safety and efficacy as both an induction and maintenance therapy. The filing also includes
Doripenem belongs to a class of antibacterial agents called carbapenems, which are useful in treating life-threatening infections caused by gram-positive and resistant gram-negative bacteria. Pseudomonas, a gram-negative bacterium,
Amoxicillin Pulsys has previously faced setbacks when the drug failed clinical trials. However a recent phase III trial of Amoxicillin Pulsys successfully met its primary and secondary endpoints.
Daronrix is intended for the prevention of influenza during a pandemic situation, once the pandemic viral strain has been included. The mock-up pandemic influenza vaccine is not expected